Actively Recruiting
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
Led by Asociación para Evitar la Ceguera en México · Updated on 2025-12-08
12
Participants Needed
1
Research Sites
161 weeks
Total Duration
On this page
Sponsors
A
Asociación para Evitar la Ceguera en México
Lead Sponsor
E
Emmecell
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical study is to assess the safety of multiple intracameral injections of EO2002 with and without topical Ripasudil.
CONDITIONS
Official Title
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be 18 years of age or older
- Have an eye that is phakic or has a posterior chamber intraocular lens (lens in the bag or sulcus)
- Have symptomatic corneal edema linked to endothelial dysfunction, possibly due to Fuchs' corneal dystrophy or pseudophakic bullous keratopathy
You will not qualify if you...
- Have any other corneal disease
- Have an anterior chamber intraocular lens
- Have a sutured or scleral-fixated intraocular lens
- Have macular disease that limits vision improvement
- Have a history of refractive surgery
- Have had a vitrectomy
- Have Descemet membrane detachment
- Have a history of uveitis or other ocular inflammatory disease
- Have had incisional glaucoma surgery (e.g., trabeculectomy, glaucoma drainage implant)
- Have intraocular pressure greater than 21 or less than 7 mm Hg
- Have had incisional eye surgery within 3 months before treatment or penetrating/endothelial keratoplasty
- Have a history of ocular neoplasm
- Have vision worse than 20/200 in the fellow eye
- Are pregnant, nursing, planning pregnancy, or not using reliable contraception if able to become pregnant
- Are currently or were recently (within 3 months) in another clinical trial involving investigational drugs
- Have any medical or psychological condition that could interfere with participation or is unsuitable by investigator judgment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Asociacion para Evitar la Ceguera en Mexico
Mexico City, Mexico City, Mexico, 04030
Actively Recruiting
Research Team
Y
Yara Luna
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here